Sumatriptan Succinate Tablets SPE2D223R0003
Summary
AI-generated · Aug 24, 2025Option Year Two for Sumatriptan Succinate Tablets is being exercised, extending the current contract for a one-year period to continue delivery of the product. The modification SPE2D223D0009 P00002 implements the extension and awards the option year to Golden State Medical Supply Inc for approximately $14,927,157.36.
Modification SPE2D223D0009 P00002 posted to announce exercising of Option Year Two (2), effective July 25, 2025 through July 24, 2026.
From Award Notice posted on Jul 03, 2025Notice history
1-
Award Notice LATEST Posted Jul 03, 2025
Details
Award Information
Award Notices
Posted: Jul 03, 2025
Modification SPE2D223D0009 P00002 posted to announce exercising of Option Year Two (2), effective July 25, 2025 through July 24, 2026.
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY INC | GQLDJJ8AQNN5 | 1HT23 | Camarillo, CA |
Contacts
Phone
Phone
Agency
Place of Performance
AUS